West Palm Beach, FL. – Stanmore Medical Investments announced today its intentions to commit capital to the medical device industry. SMI will be making investments of $250,000 to $2,000,000 in early to growth stage start-ups addressing unmet needs in the neurosurgical, orthopedic and gastroenterological specialties.
“There is a drought of capital available to device start-ups in these specialties,” commented Todd Saunders, a Principal at SMI. “The opinion that innovation is dead and regulatory uncertainty will translate into insurmountable approval hurdles is widely popular right now. We couldn’t disagree more. The healthcare industry desperately needs technologies capable of improving patient safety and reducing costs. There are brilliant people creating elegantly simple solutions to serious problems. We will help get these solutions to market.”
SMI’s team comprises seasoned leaders in the health care real estate, corporate finance, and medical technology product management fields. SMI will bring capital, discipline and growth to its company partners through a collaborative process that is informed, decisive, and transparent.
Please direct inquiries to Todd Saunders.